MedTrace Logo

Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis

NCT07694466 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-07-10

No results posted yet for this study

Summary

This outpatient study examines how inhaled cannabis, combustible or vaporized, alters lung health and breath biomarkers compared to a tobacco cigarette.

Conditions

  • Cannabis Use
  • Tobacco
  • Biomarkers

Interventions

DRUG

Cannabis (THC)

Active Cannabis (THC) will be inhaled.

DRUG

Tobacco Cigarette

A leading brand of tobacco cigarette (\~1.0 gram; Marlboro Gold; Phillip Morris International)

Sponsors & Collaborators

  • Hannah Harris

    lead OTHER

Principal Investigators

  • Hannah M Harris, Ph.D. · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-02-01
Completion
2027-06-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07694466 on ClinicalTrials.gov